Petersen, W., Liu, J., Yuan, L., Zhang, H., Schneiderjan, M., Cho, Y., & MacDonald, T. J. (2014). Dasatinib suppression of medulloblastoma survival and migration is markedly enhanced by combining treatment with the aurora kinase inhibitor AT9283.

Petersen, William, Jingbo Liu, Liangping Yuan, Hongying Zhang, Matthew Schneiderjan, Yoon-Jae Cho, και Tobey J. MacDonald. Dasatinib Suppression of Medulloblastoma Survival and Migration Is Markedly Enhanced By Combining Treatment With the Aurora Kinase Inhibitor AT9283. 2014.

Petersen, William, et al. Dasatinib Suppression of Medulloblastoma Survival and Migration Is Markedly Enhanced By Combining Treatment With the Aurora Kinase Inhibitor AT9283. 2014.